FDA grants Breakthrough Therapy status for a promising new drug targeting the rare and fatal Sanfilippo Syndrome Type B.
The biotech firm secured its sixth approval for the ZORYVE franchise, expanding its dermatology treatment to children as young as two.
The all-stock deal marks a significant move in the ongoing consolidation wave among U.S. regional banks, creating a new top-ten lender.
The executive search firm's shares jumped over 19% after agreeing to an all-cash acquisition by an investor group led by Advent International and Corvex.
All-stock transaction marks significant consolidation in the regional banking sector, creating the 9th largest U.S. bank by assets.
The all-cash deal, valued at $210 per share, paves the way for the creation of a diversified energy and industrial technology leader.
Acquisition of a 49% stake from EDP Renewables adds 1.6 GW of solar, wind, and battery storage assets across the U.S.
The unsolicited offer represents a 53% premium, as Mobix escalates its takeover attempt for the semiconductor firm.